These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. ["Partial wrapping therapy" for recurrent hepatocellular carcinoma by transthoracic route]. Masutani S; Sasaki Y; Imaoka S; Kishimoto S; Iwamoto S; Nakamori S; Ohigashi H; Kameyama M; Hiratsuka M; Ishikawa O Gan To Kagaku Ryoho; 1993 Aug; 20(11):1489-91. PubMed ID: 8396902 [TBL] [Abstract][Full Text] [Related]
6. Hemostasis and global fibrinolytic capacity in chronic liver disease. Aytac S; Turkay C; Bavbek N; Kosar A Blood Coagul Fibrinolysis; 2007 Oct; 18(7):623-6. PubMed ID: 17890949 [TBL] [Abstract][Full Text] [Related]
7. [Changes in hemostasis during orthotopic liver transplantation and massive transfusion: a case report]. Kozek-Langenecker SA; Müller CM; Felfernig M; Zimpfer M Infusionsther Transfusionsmed; 1995 Oct; 22(5):296-300. PubMed ID: 8924744 [TBL] [Abstract][Full Text] [Related]
8. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation. Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Hamba H; Shuto T; Yamamoto T; Ikebe T; Wakasa K Hepatogastroenterology; 1999; 46(30):3212-5. PubMed ID: 10626188 [TBL] [Abstract][Full Text] [Related]
9. Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis. Ezaki T; Yamamoto K; Yamaguchi H; Sasaki Y; Ishida T; Mori M; Aimitsu S Hepatogastroenterology; 2002; 49(47):1363-8. PubMed ID: 12239943 [TBL] [Abstract][Full Text] [Related]
10. Platelet-mediated thrombolysis in patients with δ-storage pool deficiency: a thrombelastographic analysis. Brodsky MA; Machovec KA; Chambers BP; Nielsen VG Blood Coagul Fibrinolysis; 2011 Oct; 22(7):610-2. PubMed ID: 21822127 [TBL] [Abstract][Full Text] [Related]
11. Management of spontaneous bleeding due to hepatocellular carcinoma. Recordare A; Bonariol L; Caratozzolo E; Callegari F; Bruno G; Di Paola F; Bassi N Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230 [TBL] [Abstract][Full Text] [Related]
12. MR-guided percutaneous cryotherapy of malignant liver tumor under horizontal-magnetic open system: initial experience. Dohi M; Harada J; Mogami T; Fukuda K; Toyama Y; Kashiwagi H J Hepatobiliary Pancreat Surg; 2003; 10(5):360-5. PubMed ID: 14598136 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Ibrahim S; Roychowdhury A; Hean TK Am J Surg; 2007 Jul; 194(1):17-22. PubMed ID: 17560903 [TBL] [Abstract][Full Text] [Related]
14. [Selection of the therapeutic methods in recurrent patients with primary liver cancer in postoperative period]. Chen H; Wu M Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):163-4. PubMed ID: 9596949 [No Abstract] [Full Text] [Related]
16. Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies. Nouso K; Matsumoto E; Kobayashi Y; Nakamura S; Tanaka H; Osawa T; Ikeda H; Araki Y; Sakaguchi K; Shiratori Y J Gastroenterol Hepatol; 2008 Mar; 23(3):453-8. PubMed ID: 17725599 [TBL] [Abstract][Full Text] [Related]
17. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma]. Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718 [TBL] [Abstract][Full Text] [Related]
18. Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment. Yamashiki N; Yoshida H; Tateishi R; Shiina S; Teratani T; Yoshida H; Kondo Y; Oki T; Kawabe T; Omata M J Gastroenterol Hepatol; 2007 Dec; 22(12):2155-60. PubMed ID: 18031374 [TBL] [Abstract][Full Text] [Related]